{"news_desk": "Sports", "print_page": "16", "section_name": "Sports", "subsection_name": "Cycling", "byline": {"contributor": "", "original": "By GINA KOLATA", "person": [{"rank": 1, "role": "reported", "firstname": "Gina", "organization": "", "lastname": "KOLATA"}]}, "abstract": "Cyclists Fabio Taborre and Carlos Oyarzun are suspended for allegedly taking FG-4592, experimental drug that increases production of red blood cells but has not yet been approved for human consumption.", "type_of_material": "News", "word_count": "772", "lead_paragraph": "FG-4592, which increases production of red blood cells, is not approved for human consumption but nonetheless has led to two positive tests just this month.", "pub_date": "2015-07-30T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "A Drug Hits Cycling Before It Hits the Market", "print_headline": "Drug Hits Cycling Before It Hits Market"}, "snippet": "FG-4592, which increases production of red blood cells, is not approved for human consumption but nonetheless has led to two positive tests just this month.", "multimedia": [{"height": 126, "url": "images/2015/07/30/sports/29DOPING/29DOPING-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/07/30/sports/29DOPING/29DOPING-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 396, "url": "images/2015/07/30/sports/29DOPING/29DOPING-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "396", "xlarge": "images/2015/07/30/sports/29DOPING/29DOPING-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/07/30/sports/29DOPING/29DOPING-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/07/30/sports/29DOPING/29DOPING-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/07/30/sports/cycling/fabio-taborre-and-carlos-oyarzun-drug-tests-suggest-use-of-chemical-meant-for-research.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Bicycles and Bicycling", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Doping (Sports)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Oyarzun, Carlos (1981- )", "name": "persons"}, {"rank": "4", "is_major": "Y", "value": "Taborre, Fabio (1985- )", "name": "persons"}, {"rank": "6", "is_major": "N", "value": "Tests (Drug Use)", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "AstraZeneca PLC", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "FibroGen Inc.", "name": "organizations"}], "blog": [], "_id": "55b958c538f0d810f56493a8", "source": "The New York Times"}